For decades, Kansas has been very committed to the development of a comprehensive network to support research, facilitate commercialization and to promote the adoption of new technologies in the state. This is evidenced in a myriad of ways, from our ongoing Statewide Broadband Initiative to the work our state’s universities are doing to partner with businesses and commercialize cutting edge research and technology. The state has a variety of tools to support and promote new technology for companies, whether they are in the early stages of their business or more mature in their operations.
The Kansas Bioscience Authority (KBA) was created by the Kansas Economic Growth Act of 2004 to accelerate growth in the bioscience sector. Originally designed to be funded by Kansas income taxes generated by bioscience jobs with a 2019 sunset, KBA has been repositioned as a market-based, self-sustaining venture capital organization with an unlimited future. The KBA invests in agribusiness, animal health, and human health innovations. The team brings deep sector expertise and co-investors together to accelerate bioscience company growth generating results for the entrepreneur, the investor, Kansas and the world.
Agribusiness – KBA invests in disruptive technologies in agriculture, crop science and crop-derived products that provide safe and reliable protein; improves food production; increases yield; leads to new concepts in food storage, microbial control and food processing; and produces sustainable fuels and chemicals that can replace petrochemical derivatives.
Animal Health – located among the world’s largest concentration of animal health and nutrition companies, KBA invests in production and companion animal health innovations. Disruptive technologies that improve food safety, food production, and bring new tools and therapies to animal health are of particular interest. Human health and other biosciences often lead to novel animal health innovations.
Human Health – KBA invests in new medical devices, healthcare IT, and diagnostics that protect and advance human health. KBA looks for investments that will bring these innovations to market in ways that maximize value created by investing at key value inflection points, such as proof of concept development or early commercial success.
With this focus, KBA advances an investment model that serves the entrepreneur, the investor and Kansas:
Visit KansasBIOAuthority.org for more information.